nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adding salt to food at table as an indicator of gastric cancer risk among adults: a prospective study
|
Kronsteiner-Gicevic, Selma |
|
|
27 |
4 |
p. 714-721 |
artikel |
2 |
Adjuvant and post-recurrent treatment patterns in patients with resectable gastric cancer in Japan: a retrospective database cohort study
|
Yoshikawa, Takaki |
|
|
27 |
4 |
p. 827-839 |
artikel |
3 |
Claudin-18 status and its correlation with HER2 and PD-L1 expression in gastric cancer with peritoneal dissemination
|
Ogawa, Haruki |
|
|
27 |
4 |
p. 802-810 |
artikel |
4 |
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape
|
Morgagni, Paolo |
|
|
27 |
4 |
p. 672-674 |
artikel |
5 |
CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions
|
Herrera-Pariente, Cristina |
|
|
27 |
4 |
p. 747-759 |
artikel |
6 |
Development of a reliable surgical quality assurance tool for gastrectomy in oncological trials
|
Harris, A. |
|
|
27 |
4 |
p. 876-883 |
artikel |
7 |
Discordant PD-L1 results between 28–8 and 22C3 assays are associated with outcomes of gastric cancer patients treated with nivolumab plus chemotherapy
|
Kim, Hyung-Don |
|
|
27 |
4 |
p. 819-826 |
artikel |
8 |
Early gastric cancer with RhoGAP fusion is linked to frequent nodal metastasis and a part of microtubular–mucocellular histology
|
Noda, Hiroto |
|
|
27 |
4 |
p. 772-784 |
artikel |
9 |
Factors associated with the efficacy of first-line nivolumab plus chemotherapy in advanced gastric cancer patients with deficient mismatch repair
|
Park, Young-Gyu |
|
|
27 |
4 |
p. 840-849 |
artikel |
10 |
Family history and gastric cancer incidence and mortality in Asia: a pooled analysis of more than half a million participants
|
Huang, Dan |
|
|
27 |
4 |
p. 701-713 |
artikel |
11 |
Feasibility of intraoperative pathologic examination for sentinel lymph nodes during sentinel node navigation surgery in early gastric cancer: results of pathologic protocol for SENORITA trial
|
Park, Sin Hye |
|
|
27 |
4 |
p. 858-868 |
artikel |
12 |
Genome-wide 5-hydroxymethylcytosines in circulating cell-free DNA as noninvasive diagnostic markers for gastric cancer
|
Fu, Yingli |
|
|
27 |
4 |
p. 735-746 |
artikel |
13 |
Global burden of young-onset gastric cancer: a systematic trend analysis of the global burden of disease study 2019
|
Li, Yunhao |
|
|
27 |
4 |
p. 684-700 |
artikel |
14 |
Identification of maximal tumor size associated with negligible lymph node metastasis for endoscopic submucosal dissection of undifferentiated-type early gastric cancer
|
Oh, Sung Eun |
|
|
27 |
4 |
p. 850-857 |
artikel |
15 |
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape
|
Morgagni, Paolo |
|
|
27 |
4 |
p. 649-671 |
artikel |
16 |
Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer
|
Kim, Hyung-Don |
|
|
27 |
4 |
p. 884-885 |
artikel |
17 |
Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer
|
Furukawa, Kenichiro |
|
|
27 |
4 |
p. 760-771 |
artikel |
18 |
Precise highlighting of the pancreas by semantic segmentation during robot-assisted gastrectomy: visual assistance with artificial intelligence for surgeons
|
Nakamura, Tatsuro |
|
|
27 |
4 |
p. 869-875 |
artikel |
19 |
Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer
|
Oh, Chung Ryul |
|
|
27 |
4 |
p. 811-818 |
artikel |
20 |
Revisiting the use of the EORTC QLQ-STO22 to assess health-related quality of life of patients with gastric cancer: incorporating updated treatment options and cross-cultural perspectives
|
Sodergren, S. C. |
|
|
27 |
4 |
p. 722-734 |
artikel |
21 |
Risk prediction model for gastric cancer within 5 years in healthy Korean adults
|
Oh, Hyungseok |
|
|
27 |
4 |
p. 675-683 |
artikel |
22 |
YAP inhibition overcomes adaptive resistance in HER2-positive gastric cancer treated with trastuzumab via the AKT/mTOR and ERK/mTOR axis
|
Qiao, Jiao |
|
|
27 |
4 |
p. 785-801 |
artikel |